Respiratory Distress Syndrome
Basics
Description
Respiratory distress syndrome (RDS) is an acute, developmental lung disease affecting primarily premature infants. Disease is characterized by alveolar collapse due to a lack of pulmonary surfactant owing to lung immaturity that results in increased work of breathing, hypoxemia, and respiratory acidosis. The term hyaline membrane disease (HMD) is often used synonymously.
Epidemiology
- RDS is the most common lung disease in premature infants, affecting approximately 60,000 to 80,000 infants per year in the United States.
- Risk increases with the degree of prematurity; nearly 100% of infants born at <26 weeks’ gestation affected
- For near-term infants delivered operatively without benefit of labor, the risk of developing RDS increases roughly 2-fold for every week <39 weeks’ gestation.
Risk Factors
- Prematurity
- Low birth weight
- Maternal diabetes
- Delivery without labor
- Absence of antenatal steroid administration
- Male gender
- Caucasian race
- Perinatal depression
General Prevention
- Prevention of prematurity
- Maternal antenatal steroids
Pathophysiology
- Insufficient or dysfunctional surfactant results in alveolar instability and atelectasis, causing hypoventilation and ventilation–perfusion mismatch, leading to hypoxemia and respiratory acidosis.
- The lack of surfactant in conjunction with pulmonary immaturity also leads to transudation of fluid and alveolar edema.
- Surfactant inactivation from transudation of proteins or other substances into the alveolus
- Increased work of breathing generates high negative intrathoracic pressures to overcome alveolar collapse. Retractions result from the highly compliant newborn rib cage combined with poorly compliant lungs.
- Expiratory grunting is due to glottic closure at the end of expiration to prevent end-expiratory atelectasis and maintain functional residual capacity.
- Infants with a well-developed pulmonary arterial muscular bed can develop secondary pulmonary hypertension, with hypoxemia leading to pulmonary vasoconstriction.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Cabana, Michael D., editor. "Respiratory Distress Syndrome." 5-Minute Pediatric Consult, 8th ed., Wolters Kluwer, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618147/all/Respiratory_Distress_Syndrome.
Respiratory Distress Syndrome. In: Cabana MDM, ed. 5-Minute Pediatric Consult. Wolters Kluwer; 2019. https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618147/all/Respiratory_Distress_Syndrome. Accessed October 15, 2024.
Respiratory Distress Syndrome. (2019). In Cabana, M. D. (Ed.), 5-Minute Pediatric Consult (8th ed.). Wolters Kluwer. https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618147/all/Respiratory_Distress_Syndrome
Respiratory Distress Syndrome [Internet]. In: Cabana MDM, editors. 5-Minute Pediatric Consult. Wolters Kluwer; 2019. [cited 2024 October 15]. Available from: https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618147/all/Respiratory_Distress_Syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Respiratory Distress Syndrome
ID - 618147
ED - Cabana,Michael D,
BT - 5-Minute Pediatric Consult
UR - https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618147/all/Respiratory_Distress_Syndrome
PB - Wolters Kluwer
ET - 8
DB - Pediatrics Central
DP - Unbound Medicine
ER -